Pollution of Aqueous Matrices with Pharmaceuticals

  • Kriti Jindal
  • Mallikarjun Narayanam
  • Saranjit SinghEmail author


The world is witnessing an increasing contamination of the environment by pharmaceuticals due to their escalating consumption and recalcitrant nature. Water bodies like rivers, lakes and even surface water have been found to be contaminated with drugs. Exposure to these contaminants is already showing detrimental effects in fish, frogs, birds, etc., with the development of antibiotic-resistant pathogens being another repercussion. Chronic exposure to pharmaceuticals, even in trace quantities, may also affect human health adversely in the long term. Although a decade back it was difficult to provide substantial data for such pollution, the recent development of highly sensitive and specific analytical tools has led to the detection of pharmaceuticals in many drinking water sources also. In this chapter, we discuss various aspects of this issue, beginning with the causes of pollution, the enormity of consequences, types of aquatic sources reported to be contaminated, drugs usually found, and finally the variety of techniques that can be used to detect and characterize pharmaceuticals in aqueous matrices.


Contamination Environment Pharmaceuticals Pollution Water 


  1. Aherne GW, Briggs R (1989) The relevance of the presence of certain synthetic steroids in the aquatic environment. J Pharm Pharmacol 41:735–736Google Scholar
  2. Aherne GW, Hardcastle A, Nield AH (1990) Cytotoxic drugs and the aquatic environment: estimation of bleomycin in river and water samples. J Pharm Pharmacol 42:741–742Google Scholar
  3. Ahrer W, Buchberger W (2001) Combination of aqueous and non-aqueous capillary electrophoresis with electrospray mass spectrometry for the determination of drug residues in water. Monatshefte für Chemie/Chemical Monthly 132:329–337Google Scholar
  4. Ahrer W, Scherwenk E, Buchberger W (2001) Determination of drug residues in water by the combination of liquid chromatography or capillary electrophoresis with electrospray mass spectrometry. J Chromatogr A 910:69–78Google Scholar
  5. Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, Handelsman J (2010) Call of the wild: antibiotic resistance genes in natural environments. Nat Rev Microbiol 8:251–259Google Scholar
  6. Andreozzi R, Canterino M, Marotta R, Paxeus N (2005) Antibiotic removal from wastewaters: the ozonation of amoxicillin. J Hazard Mater 122:243–250Google Scholar
  7. Ash RJ, Mauck B, Morgan M (2002) Antibiotic resistance of gram-negative bacteria in rivers, United States. Emerg Infect Dis 8:713–716Google Scholar
  8. Balakrishnan VK, Terry KA, Toito J (2006) Determination of sulfonamide antibiotics in wastewater: a comparison of solid phase microextraction and solid phase extraction methods. J Chromatogr A 1131:1–10Google Scholar
  9. Baranowska I, Kowalski B (2012) A rapid UHPLC method for the simultaneous determination of drugs from different therapeutic groups in surface water and wastewater. Bull Environ Contam Toxicol 89:8–14Google Scholar
  10. Behnke J (2012) Pharmaceuticals in the water: the albatross around Texas’s neck. Texas Tech Adm Law J 13:325–391Google Scholar
  11. Boxall ABA, Rudd M, Brooks BW, Caldwell D, Choi K, Hickmann S et al (2012) Pharmaceuticals and personal care products in the environment: what are the big questions. Environ Health Perspect 120:1221–1229Google Scholar
  12. Boyd GR, Reemtsma H, Grimm DA, Mitra S (2003) Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci Total Environ 311:135–149Google Scholar
  13. Brausch JM, Connors KA, Brooks BW, Rand GM (2012) Human pharmaceuticals in the aquatic environment: a review of recent toxicological studies and considerations for toxicity testing. Rev Environ Contam Toxicol 218:1–99Google Scholar
  14. Brooks BW, Foran CM, Richards SM, Weston J, Turner PK, Stanley JK et al (2003) Aquatic ecotoxicology of fluoxetine. Toxicol Lett 142:169–183Google Scholar
  15. Brooks BW, Chambliss CK, Stanley JK, Ramirez A, Banks KE, Johnson RD et al (2005) Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 24:464–469Google Scholar
  16. Brun GL, Bernier M, Losier R, Doe K, Jackman P, Lee HB (2006) Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ Toxicol Chem 25:2163–2176Google Scholar
  17. Buchberger WW (2011) Current approaches to trace analysis of pharmaceuticals and personal care products in the environment. J Chromatogr A 1218:603–618Google Scholar
  18. Buerge IJ, Buser HR, Poiger T, Muller MD (2006) Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters. Environ Sci Technol 40:7242–7250Google Scholar
  19. Buhner SH (2002) The environmental impacts of technological medicine. In: Buhner SH (ed) The lost language of plants: the ecological importance of plant medicines to life on Earth. Chelsea Green Publishing, Vermont, pp 92–101Google Scholar
  20. Cahill JD, Furlong ET, Burkhardt MR, Kolpin D, Anderson LG (2004) Determination of pharmaceutical compounds in surface- and ground-water samples by solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr A 1041:171–180Google Scholar
  21. Calza P, Marchisio S, Medana C, Baiocchi C (2010) Fate of antibacterial spiramycin in river waters. Anal Bioanal Chem 396:1539–1550Google Scholar
  22. Castiglioni S, Bagnati R, Calamari D, Fanelli R, Zuccato E (2005) A multiresidue analytical method using solid-phase extraction and high-pressure liquid chromatography tandem mass spectrometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters. J Chromatogr A 1092:206–215Google Scholar
  23. Castiglioni S, Bagnati R, Fanelli R, Pomati F, Calamari D, Zuccato E (2006) Removal of pharmaceuticals in sewage treatment plants in Italy. Environ Sci Technol 40:357–363Google Scholar
  24. Cecinato A, Balducci C, Nervegna G (2009) Occurrence of cocaine in the air of the world’s cities: an emerging problem? A new tool to investigate the social incidence of drugs? Sci Total Environ 407:1683–1690Google Scholar
  25. Central Pollution Control Board (1989) Minimal national standards, pharmaceutical manufacturing and formulation industry. Comprehensive industry document series: COINDS/29/1988-89, New Delhi, IndiaGoogle Scholar
  26. Chenxi W, Spongberg AL, Witter JD (2008) Determination of the persistence of pharmaceuticals in biosolids using liquid-chromatography tandem mass spectrometry. Chemosphere 73:511–518Google Scholar
  27. Cheung M (2011) Embryotoxicity of fluoxetine (Prozac®) to Japanese medaka (Oryzias latipes). Bachelor of Science (Honours) Thesis. School of Environmental Studies, Queen’s University, CanadaGoogle Scholar
  28. Christensen FM (1998) Pharmaceuticals in the environment-a human risk? Regul Toxicol Pharmacol 28:212–221Google Scholar
  29. Chu S, Metcalfe CD (2007) Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-tandem mass spectrometry. J Chromatogr A 1163:112–118Google Scholar
  30. Daneshvar A, Svanfelt J, Kronberg L, Weyhenmeyer GA (2012) Neglected sources of pharmaceuticals in river water-footprints of a Reggae festival. J Environ Monit 14:596–603Google Scholar
  31. Daughton CG (2000) Pharmaceuticals in the environment: overarching issues and concerns. Pharmaceuticals and Personal Care Products in the Environment. San Francisco, CA, Paper presented at ACS National MeetingGoogle Scholar
  32. Deshmukh NI, Barker J, Petroczi A, Naughton DP (2011) Detection of stanozolol in environmental waters using liquid chromatography tandem mass spectrometry. Chem Cent J 5:63–70Google Scholar
  33. Díaz-Cruz M, Barceló D (2006) Determination of antimicrobial residues and metabolites in the aquatic environment by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 386:973–985Google Scholar
  34. Drewes JE, Heberer T, Rauch T, Reddersen K (2003) Fate of pharmaceuticals during ground water recharge. Ground Water Monit Rem 23:64–72Google Scholar
  35. European Medicines Agency (1996) Environmental risk assessment for veterinary medicinal products other than GMO-containing medicinal products. EMEA/CVMP/055/96-FINAL, Brussels, BelgiumGoogle Scholar
  36. Fernandez C, Gonzalez-Doncel M, Pro J, Carbonell G, Tarazona JV (2010) Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River system (Madrid, Spain) and a potential risk characterization. Sci Total Environ 408:543–551Google Scholar
  37. Ferrer I, Thurman EM (2012) Analysis of 100 pharmaceuticals and their degradates in water samples by liquid chromatography/quadrupole time-of-flight mass spectrometry. J Chromatogr A 1259:148–157Google Scholar
  38. Ferrer I, Zweigenbaum JA, Thurman EM (2010) Analysis of 70 Environmental Protection Agency priority pharmaceuticals in water by EPA method 1694. J Chromatogr A 1217:5674–5686Google Scholar
  39. Fick J, Lindberg RH, Tysklind M, Haemig PD, Waldenström J, Wallensten A et al (2007) Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus. PLoS ONE 2:986–991Google Scholar
  40. Gallart-Ayala H, Nuenz O, Moyano E, Galceran MT, Martins CPB (2011) Preventing false negatives with high-resolution mass spectrometry: the benzophenone case. Rapid Commun Mass Spectrom 25:3161–3166Google Scholar
  41. Gao P, Mao D, Luo Y, Wang L, Xu B, Xu L (2012) Occurrence of sulfonamide and tetracycline-resistant bacteria and resistance genes in aquaculture environment. Water Res 46:2355–2364Google Scholar
  42. Garcia-Ac A, Segura PA, Gagnon C, Sauve S (2009) Determination of bezafibrate, methotrexate, cyclophosphamide, orlistat and enalapril in waste and surface waters using on-line solid-phase extraction liquid chromatography coupled to polarity-switching electrospray tandem mass spectrometry. J Environ Monit 11:830–838Google Scholar
  43. Garrison AW, Pope JD, Allen FR (1976) GC/MS analysis of organic compounds in domestic wastewater. In: Keith CH (ed) Identification and analysis of organic pollutants in water. Ann Arbor Science, Ann Arbor, pp 517–566Google Scholar
  44. Godfrey E, Woessner WW, Benotti MJ (2007) Pharmaceuticals in on-site sewage effluent and ground water, Western Montana. Ground Water 45:263–271Google Scholar
  45. Golet EM, Alder AC, Hartmann A, Ternes TA, Giger W (2001) Trace determination of fluoroquinolone antibacterial agents in urban wastewater by solid-phase extraction and liquid chromatography with fluorescence detection. Anal Chem 73:3632–3638Google Scholar
  46. Green RE, Newton IAN, Shultz S, Cunningham AA, Gilbert M, Pain DJ et al (2004) Diclofenac poisoning as a cause of vulture population declines across the Indian subcontinent. J Appl Ecol 41:793–800Google Scholar
  47. Halling-Sørensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten Lützhøft HC, Jørgensen SE (1998) Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 36:357–393Google Scholar
  48. Halling-Sørensen B, Lykkeberg A, Ingerslev F, Blackwell P, Tjornelund J (2003) Characterisation of the abiotic degradation pathways of oxytetracyclines in soil interstitial water using LC–MS–MS. Chemosphere 50:1331–1342Google Scholar
  49. Heberer T, Butz S, Stan HJ (1995) Analysis of phenoxycarboxylic acids and other acidic compounds in tap, ground, surface and sewage water at the low ng/1 level. Int J Environ Anal Chem 58:43–53Google Scholar
  50. Hernando MD, Gomez MJ, Aguera A, Fernandez-Alba AR (2007) LC-MS analysis of basic pharmaceuticals (beta-blockers and anti-ulcer agents) in wastewater and surface water. TrAC Trends Anal Chem 26:581–594Google Scholar
  51. Hignite C, Azarnoff DL (1977) Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicyclic acid in sewage water effluent. Life Sci 20:337–341Google Scholar
  52. Hogenboom AC, van Leerdam JA, de Voogt P (2009) Accurate mass screening and identification of emerging contaminants in environmental samples by liquid chromatography-hybrid linear ion trap orbitrap mass spectrometry. J Chromatogr A 1216:510–519Google Scholar
  53. Hruska K, Franek M (2012) Sulfonamides in the environment: a review and a case report. Vet Med 57:1–35Google Scholar
  54. International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (2000) Environmental impact assessment (EIAs) for veterinary medicinal products (VMPs)—phase I. VICH GL 6 (Ecotoxicity phase I), Brussels, BelgiumGoogle Scholar
  55. International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (2005) Environmental impact assessment for veterinary medicinal products phase II guidance. VICH GL 38 (Ecotoxicity phase II), Brussels, BelgiumGoogle Scholar
  56. Isidori M, Parrella A, Pistillo P, Temussi F (2009) Effects of ranitidine and its photoderivatives in the aquatic environment. Environ Int 35:821–825Google Scholar
  57. Jindal K (2012) Determination of trace pharmaceuticals in the environment using advanced analytical modalities. Master of Science (Pharm.) Thesis. Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Punjab, IndiaGoogle Scholar
  58. Jones OA, Voulvoulis N, Lester JN (2004) Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment. Crit Rev Toxicol 34:335–350Google Scholar
  59. Kallio JM, Lahti M, Oikari A, Kronberg L (2010) Metabolites of the aquatic pollutant diclofenac in fish bile. Environ Sci Technol 44:7213–7219Google Scholar
  60. Kim SD, Cho J, Kim IS, Vanderford BJ, Snyder SA (2007a) Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res 41:1013–1021Google Scholar
  61. Kim Y, Choi K, Jung J, Park S, Kim PG, Park J (2007b) Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ Int 33:370–375Google Scholar
  62. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB et al (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999–2000: a national reconnaissance. Environ Sci Technol 36:1202–1211Google Scholar
  63. Kulkarni GK, Nagabhushanam R, Amaldoss G, Jaiswal RG, Fingerman M (1992) In vivo stimulation of ovarian development in the red swamp crayfish, Procambarus clarkii (Girard), by 5-hydroxytryptamine. Invertebr Reprod Develop 21:231–239Google Scholar
  64. Kümmerer K, Helmers E (1997) Hospital effluents as a source for platinum in the environment. Sci Total Environ 193:179–184Google Scholar
  65. Kvarnryd M, Grabic R, Brandt I, Berg C (2011) Early life progestin exposure causes arrested oocyte development, oviductal agenesis and sterility in adult Xenopus tropicalis frogs. Aquat Toxicol 103:18–24Google Scholar
  66. Lee HB, Peart TE, Svoboda ML, Backus S (2009) Occurrence and fate of rosuvastatin, rosuvastatin lactone, and atorvastatin in Canadian sewage and surface water samples. Chemosphere 77:1285–1291Google Scholar
  67. Li D, Yang M, Hu J, Zhang J, Liu R, Gu X et al (2009) Antibiotic-resistance profile in environmental bacteria isolated from penicillin production wastewater treatment plant and the receiving river. Environ Microbiol 11:1506–1517Google Scholar
  68. Liu X, Lee J, Ji K, Takeda S, Choi K (2012) Potentials and mechanisms of genotoxicity of six pharmaceuticals frequently detected in freshwater environment. Toxicol Lett 211:70–76Google Scholar
  69. Macia A, Borrull F, Calull M, Aguilar C (2004) Determination of some acidic drugs in surface and sewage treatment plant waters by capillary electrophoresis-electrospray ionization-mass spectrometry. Electrophoresis 25:3441–3449Google Scholar
  70. Martinez NA, Schneider RJ, Messina GA, Raba J (2010) Modified paramagnetic beads in a microfluidic system for the determination of ethinylestradiol (EE2) in river water samples. Biosens Bioelectron 25:1376–1381Google Scholar
  71. Martinez NA, Pereira SV, Bertolino FA, Schneider RJ, Messina GA, Raba J (2012) Electrochemical detection of a powerful estrogenic endocrine disruptor: ethinylestradiol in water samples through bioseparation procedure. Anal Chim Acta 723:27–32Google Scholar
  72. Mennigen JA, Sassine J, Trudeau VL, Moon TW (2010) Waterborne fluoxetine disrupts feeding and energy metabolism in the goldfish Carassius auratus. Aquat Toxicol 100:128–137Google Scholar
  73. Metcalfe CD, Koenig BG, Bennie DT, Servos M, Ternes TA, Hirsch R (2003) Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ Toxicol Chem 22:2872–2880Google Scholar
  74. Miao X-S, Metcalfe CD (2003) Determination of cholesterol-lowering statin drugs in aqueous samples using liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr A 998:133–141Google Scholar
  75. Miege C, Budzinski H, Jacquet R, Soulier C, Pelte T, Coquery M (2012) Polar organic chemical integrative sampler (POCIS): application for monitoring organic micropollutants in wastewater effluent and surface water. J Environ Monit 14:626–635Google Scholar
  76. Miller CS (1997) Toxicant-induced loss of tolerance-an emerging theory of disease? Environ Health Perspect 105:445–453Google Scholar
  77. Mimeault C, Woodhouse AJ, Miao XS, Metcalfe CD, Moon TW, Trudeau VL (2005) The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus. Aquat Toxicol 73:44–54Google Scholar
  78. Ministry of Environment and Forests (2011) Bio-medical waste (management and handling) rules, IndiaGoogle Scholar
  79. Möder M, Braun P, Lange F, Schrader S, Lorenz W (2007) Determination of endocrine disrupting compounds and acidic drugs in water by coupling of derivatization, gas chromatography and negative-chemical ionization mass spectrometry. CLEAN—Soil, Air, Water 35:444–451Google Scholar
  80. Montforts MHMM, Kalf DF, van Vlaardingen PLA, Linders JBHJ (1999) The exposure assessment for veterinary medicinal products. Sci Total Environ 225:119–133Google Scholar
  81. Nentwig G (2007) Effects of pharmaceuticals on aquatic invertebrates. Part II: the antidepressant drug fluoxetine. Arch Environ Contam Toxicol 52:163–170Google Scholar
  82. Obando MA, Estela JM, Cerda V (2008) Multi-syringe chromatography (MSC) system for the on-line solid-phase extraction and determination of hydrochlorothiazide and losartan potassium in superficial water, groundwater and wastewater outlet samples. J Pharm Biomed Anal 48:212–217Google Scholar
  83. Okuda T, Yamashita N, Tanaka H, Matsukawa H, Tanabe K (2009) Development of extraction method of pharmaceuticals and their occurrences found in Japanese wastewater treatment plants. Environ Int 35:815–820Google Scholar
  84. Paxeus N (2004) Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci Technol 50:253–260Google Scholar
  85. Peck AM (2006) Analytical methods for the determination of persistent ingredients of personal care products in environmental matrices. Anal Bioanal Chem 386:907–939Google Scholar
  86. Petrovic M, Gros M, Barcelo D (2006) Multi-residue analysis of pharmaceuticals in wastewater by ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry. J Chromatogr A 1124:68–81Google Scholar
  87. Petrovic M, De Alda MJL, Diaz-Cruz S, Postigo C, Radjenovic J, Gros M et al (2009) Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration. Philos Trans R Soc A: Math Phys Eng Sci 367:3979–3989Google Scholar
  88. Petrovic M, Farre M, de Alda ML, Perez S, Postigo C, Kock M et al (2010) Recent trends in the liquid chromatography-mass spectrometry analysis of organic contaminants in environmental samples. J Chromatogr A 1217:4004–4017Google Scholar
  89. PharmEcology Associates, LLC (2008) Managing pharmaceutical waste. A 10-Step blueprint for healthcare facilities in the United States, Houston, U.S.AGoogle Scholar
  90. Pomati F, Castiglioni S, Zuccato E, Fanelli R, Vigetti D, Rossetti C et al (2006) Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environ Sci Technol 40:2442–2447Google Scholar
  91. Qin F, Zhao YY, Sawyer MB, Li XF (2008) Column-switching reversed phase-hydrophilic interaction liquid chromatography/tandem mass spectrometry method for determination of free estrogens and their conjugates in river water. Anal Chim Acta 627:91–98Google Scholar
  92. Radjenovic J, Petrovic M, Barceló D (2007) Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal Bioanal Chem 387:1365–1377Google Scholar
  93. Radjenovic J, Petrovic M, Ventura F, Barcelo D (2008) Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. Water Res 42:3601–3610Google Scholar
  94. Razavi B, Ben Abdelmelek S, Song W, O’Shea KE, Cooper WJ (2011) Photochemical fate of atorvastatin (lipitor) in simulated natural waters. Water Res 45:625–631Google Scholar
  95. Richardson ML, Bowron JM (1985) The fate of pharmaceutical chemicals in the aquatic environment. J Pharm Pharmacol 37:1–12Google Scholar
  96. Sarmah AK, Meyer MT, Boxall ABA (2006) A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere 65:725–759Google Scholar
  97. Schwab BW, Hayes EP, Fiori JM, Mastrocco FJ, Roden NM, Cragin D et al (2005) Human pharmaceuticals in US surface waters: a human health risk assessment. Regul Toxicol Pharmacol 42:296–312Google Scholar
  98. Schwaiger J, Ferling H, Mallow U, Wintermayr H, Negele RD (2004) Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 68:141–150Google Scholar
  99. Sebok A, Vasanits-Zsigrai A, Palko G, Zaray G, Molnar-Perl I (2008) Identification and quantification of ibuprofen, naproxen, ketoprofen and diclofenac present in waste-waters, as their trimethylsilyl derivatives, by gas chromatography mass spectrometry. Talanta 76:642–650Google Scholar
  100. Singer AC, Nunn MA, Gould EA, Johnson AC (2007) Potential risks associated with the proposed widespread use of tamiflu. Environ Health Perspect 115:102–106Google Scholar
  101. Teijon G, Candela L, Tamoh K, Molina-Diaz A, Fernandez-Alba AR (2010) Occurrence of emerging contaminants, priority substances (2008/105/CE) and heavy metals in treated wastewater and groundwater at Depurbaix facility (Barcelona, Spain). Sci Total Environ 408:3584–3595Google Scholar
  102. Ternes TA (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245–3260Google Scholar
  103. Ternes T, Bonerz M, Schmidt T (2001) Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 938:175–185Google Scholar
  104. Tong L, Li P, Wang Y, Zhu K (2009) Analysis of veterinary antibiotic residues in swine wastewater and environmental water samples using optimized SPE-LC/MS/MS. Chemosphere 74:1090–1097Google Scholar
  105. United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) (1998) Guidance for industry: environmental assessment of human drug and biologics applications, Rockville, U.S.AGoogle Scholar
  106. United States Environmental Protection Agency (1976) Resources conservation and recovery act (RCRA), Washington, U.S.AGoogle Scholar
  107. United States Environmental Protection Agency. 2002. Federal water pollution control act. Q:\COMP\WATER2\CLEANWAT.001, Washington, U.S.AGoogle Scholar
  108. United States Environmental Protection Agency (2010) Best management practices for unused pharmaceuticals at health care facilities. EPA-821-R-10-006, Washington, U.S.AGoogle Scholar
  109. United States Food and Drug Administration (2011) How to dispose of unused medicines, Rockville, U.S.AGoogle Scholar
  110. United States Senate (2007) The preservation of antibiotics for medical treatment act. Senate Bill, S.549. U.S.AGoogle Scholar
  111. van Leerdam JA, Hogenboom AC, van der Kooi MME, de Voogt P (2009) Determination of polar 1H-benzotriazoles and benzothiazoles in water by solid-phase extraction and liquid chromatography LTQ FT orbitrap mass spectrometry. Int J Mass Spectrom 282:99–107Google Scholar
  112. Vanderford BJ, Snyder SA (2006) Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environ Sci Technol 40:7312–7320Google Scholar
  113. Velagaleti R, Burns PK, Gill M, Prothro J (2002) Impact of current good manufacturing practices and emission regulations and guidances on the discharge of pharmaceutical chemicals into the environment from manufacturing, use, and disposal. Environ Health Perspect 110:213–220Google Scholar
  114. Vera-Candioti L, Gil García MD, Martínez Galera M, Goicoechea HC (2008) Chemometric assisted solid-phase microextraction for the determination of anti-inflammatory and antiepileptic drugs in river water by liquid chromatography-diode array detection. J Chromatogr A 1211:22–32Google Scholar
  115. Vieno N, Tuhkanen T, Kronberg L (2007) Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res 41:1001–1012Google Scholar
  116. Waggot A (1981) Trace organic substances in the river Lee (Great Britain). In: Cooper WJ (ed) Chemistry in water reuse. Ann Arbor Science, Ann Arbor, pp 55–99Google Scholar
  117. Webb S, Ternes T, Gibert M, Olejniczak K (2003) Indirect human exposure to pharmaceuticals via drinking water. Toxicol Lett 142:157–167Google Scholar
  118. Wicher K, Reisman RE (1980) Anaphylactic reaction to penicillin (or penicillin-like substance) in a soft drink. J Allergy Clin Immunol 66:155–157Google Scholar
  119. World Health Organization (1999) Guidelines for safe disposal of unwanted pharmaceuticals in and after emergencies. WHO/EDM/PAR/99.2, Geneva, SwitzerlandGoogle Scholar
  120. World Health Organization (2011) Guidelines for drinking-water quality, 4th edn. Switzerland, GenevaGoogle Scholar
  121. World Health Organization (2012) Pharmaceuticals in drinking-water. WHO/HSE/WSH/11.05, Geneva, SwitzerlandGoogle Scholar
  122. Zhang Y, Geissen SU, Gal C (2008) Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 73:1151–1161Google Scholar
  123. Zuccato E, Castiglioni S, Fanelli R (2005) Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. J Hazard Mater 122:205–209Google Scholar

Copyright information

© Springer India 2014

Authors and Affiliations

  • Kriti Jindal
    • 1
  • Mallikarjun Narayanam
    • 1
  • Saranjit Singh
    • 1
    Email author
  1. 1.Department of Pharmaceutical AnalysisNational Institute of Pharmaceutical Education and ResearchS. A. S. NagarIndia

Personalised recommendations